The company is engaged in pharmaceutical production, general trading and agency. Currently, the Company's main activities are producing “IV Solution”, and injection of raw material components (dextrose). The company produces various types of intravenous fluids, which are labeled "FIMALBUMIN" and "OCTALBIN". The product consists of more than 10 items of intravenous fluids with various contents, such as; NaCl 0.9%, Dextrose 0.5%, 5%, 10%, Ringer's Lactate; Dextral L, etc. Marketed by Kalbe Farma Group, and is fully aimed at meeting the domestic market. The Company's production utility in 2008 is estimated at 7,000,000 liters of intravenous fluids. The company started commercial operations in 1981. The company has 65 employees.
Currently PT Finusolprima Farma Internasional (A Kalbe Company) is re-opening new job vacancies in December 2020. Below are the positions currently available to you job seekers who are interested in developing your career with PT Finusolprima Farma Internasional (A Kalbe Company) with the following qualifications.